What is the recommended dose and frequency of urea (Urea) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urea Dosing and Administration Guidelines

For hemodialysis patients, the target dose for urea clearance should be a single-pool Kt/V (spKt/V) of 1.4 per dialysis session when administered three times per week, with a minimally adequate dose of spKt/V of 1.2 per session. 1

Hemodialysis Dosing Parameters

Standard Three-Times Weekly Hemodialysis

  • The minimally adequate dose of hemodialysis given 3 times per week to patients with residual kidney function (Kr) less than 2 mL/min/1.73 m² should be an spKt/V of 1.2 per dialysis 1
  • For treatment times less than 5 hours, an alternative minimum dose is a urea reduction ratio (URR) of 65% 1
  • The target dose should be an spKt/V of 1.4 per dialysis or URR of 70% 1

Patients with Residual Kidney Function

  • In patients with residual urea clearance (Kr) greater than or equal to 2 mL/min/1.73 m², the minimum session spKt/V can be reduced 1
  • For these patients, the target spKt/V should be at least 15% greater than the minimum dose 1

Peritoneal Dialysis Dosing

CAPD (Continuous Ambulatory Peritoneal Dialysis)

  • The minimal "delivered" dose of total small-solute clearance should be a total (peritoneal and kidney) Kt/V urea of at least 1.7 per week 1
  • This is a revision from previous guidelines that recommended a weekly Kt/V urea of 2.0 1
  • Total solute clearance should be measured within the first month after initiating dialysis therapy and at least once every 4 months thereafter 1

Residual Kidney Function Monitoring

  • If the patient has greater than 100 mL/d of residual kidney volume, a 24-hour urine collection for urine volume and solute clearance determinations should be obtained at minimum every 2 months 1

Monitoring and Compliance

Frequency of Measurement

  • Kt/V urea should be measured within the first month after initiating dialysis therapy and at least once every 4 months thereafter 1
  • Efforts should be made to monitor and minimize the occurrence of missed or shortened treatments, as these significantly impact outcomes 1

Sampling Methods

  • When using the stop-dialysate-flow method for blood sampling, blood flow must not be reduced as dialysate needs to equilibrate with blood quickly 1
  • A 3-minute waiting period after stopping dialysate flow is sufficient for equilibration 1

Special Considerations

Alternative Dialysis Schedules

  • For twice-weekly hemodialysis schedules, patients should have substantial residual kidney function 1
  • The same minimum levels of spKt/V are recommended for hemofiltration and hemodiafiltration as for standard hemodialysis 1

Urea for Hyponatremia Treatment

  • For hyponatremia treatment, particularly in SIADH, urea is typically administered at doses of 0.25-0.50 g/kg/day 2
  • A median dose of 30 g/day has been shown to effectively increase serum sodium levels 3, 4
  • Patient tolerance may be an issue, with distaste being a common side effect, though it rarely leads to treatment discontinuation 2, 4

Pitfalls and Caveats

  • Overcorrection of serum sodium (increase >8 mEq/L in 24 hours) can occur in approximately 8% of patients treated with urea for hyponatremia 3
  • The stop-dialysate-flow method has not been validated during pediatric dialysis 1
  • With large dialyzers used at relatively lower blood flow rates, dialyzer outlet blood may still have substantially lower urea concentration than inlet blood after 3 minutes of stopping dialysate flow 1
  • Patient compliance with dialysis schedules significantly impacts outcomes, with missed treatments being an important predictor of mortality and hospitalizations 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety and Efficacy of Urea for Hyponatremia.

Hospital pharmacy, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.